Over the past 12 months, 0 insiders at Eliem Therapeutics, Inc. filed 0 open-market SEC Form 4 transactions on ELYM: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 20, 24 | Emily PimblettCHIEF ACCOUNTING OFFICER | SELL | 1.2K | $8.18 | $10K |
| Jul 22, 24 | Valerie MorissetEVP, R&D AND CSO | SELL | 39.0K | $8.07 | $315K |
| Jul 19, 24 | Valerie MorissetEVP, R&D AND CSO | SELL | 50.0K | $7.24 | $362K |
| Jul 18, 24 | Valerie MorissetEVP, R&D AND CSO | SELL | 38.6K | $6.93 | $267K |
| Jul 17, 24 | Valerie MorissetEVP, R&D AND CSO | SELL | 3.2K | $6.91 | $22K |
| Jul 16, 24 | Valerie MorissetEVP, R&D AND CSO | SELL | 50.0K | $7.13 | $357K |
| Jul 15, 24 | Valerie MorissetEVP, R&D AND CSO | SELL | 42.4K | $7.01 | $297K |
| Jul 12, 24 | Valerie MorissetEVP, R&D AND CSO | SELL | 50.0K | $7.07 | $354K |
| Jul 11, 24 | Valerie MorissetEVP, R&D AND CSO | SELL | 50.0K | $7.11 | $356K |
| Jul 10, 24 | Valerie MorissetEVP, R&D AND CSO | SELL | 50.0K | $6.83 | $342K |
| Jul 9, 24 | Valerie MorissetEVP, R&D AND CSO | SELL | 5.9K | $6.66 | $40K |
| Jul 5, 24 | Valerie MorissetEVP, R&D AND CSO | SELL | 12.3K | $7.06 | $87K |
| Jul 3, 24 | Valerie MorissetEVP, R&D AND CSO | SELL | 50.0K | $6.76 | $338K |
| Jun 27, 24 | Peter KolchinskyDirector,TenPercentOwner | BUY | 11.95M | $3.84 | $45.9M |
| Jun 20, 24 | Emily PimblettCHIEF ACCOUNTING OFFICER | SELL | 1.2K | $7.21 | $9K |
| Aug 12, 21 | Access Industries Holdings LlcOther | BUY | 800.0K | $12.50 | $10.0M |
| Aug 12, 21 | Ra Capital Nexus Fund Ii, L.p.Director,TenPercentOwner | BUY | 3.00M | $12.50 | $37.6M |
Over the past 12 months, insiders at Eliem Therapeutics, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on ELYM, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market ELYM insider purchase in our data was $45.9M by Peter Kolchinsky, Director,TenPercentOwner, filed on Jun 27, 24.
0 different insiders at Eliem Therapeutics, Inc. filed open-market SEC Form 4 transactions on ELYM over the last 12 months.
InsiderTape plots every ELYM insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Eliem Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →